A corticotropin releasing factor (CRF) antagonist is administered to treat disorders that can be treated by altering circadian rhythm.

Un corticotropin che libera l'antagonista di fattore (CRF) รจ amministrato per trattare i disordini che possono essere trattati alterando il ritmo circadiano.

 
Web www.patentalert.com

< Polymorphic form of a tachykinin receptor antagonist

< Polymorphic form of a tachykinin receptor antagonist

> Treatment of cardiovascular disease

> Trisubstituted-oxazole derivatives as serotonin ligands

~ 00041